Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Times Interest Earned (2020 - 2025)

Mirum Pharmaceuticals has reported Times Interest Earned over the past 6 years, most recently at -$1.27 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$1.27 for Q4 2025, up 81.24% from a year ago — trailing twelve months through Dec 2025 was -$1.54 (up 74.87% YoY), and the annual figure for FY2025 was -$1.54, up 74.87%.
  • Times Interest Earned for Q4 2025 was -$1.27 at Mirum Pharmaceuticals, down from $0.72 in the prior quarter.
  • Over the last five years, Times Interest Earned for MIRM hit a ceiling of $0.72 in Q3 2025 and a floor of -$14.08 in Q1 2021.
  • Median Times Interest Earned over the past 5 years was -$7.22 (2023), compared with a mean of -$6.71.
  • Biggest five-year swings in Times Interest Earned: dropped 16.7% in 2023 and later soared 120.41% in 2025.
  • Mirum Pharmaceuticals' Times Interest Earned stood at -$12.1 in 2021, then soared by 35.24% to -$7.84 in 2022, then fell by 16.7% to -$9.15 in 2023, then increased by 26.0% to -$6.77 in 2024, then skyrocketed by 81.24% to -$1.27 in 2025.
  • The last three reported values for Times Interest Earned were -$1.27 (Q4 2025), $0.72 (Q3 2025), and -$1.39 (Q2 2025) per Business Quant data.